Promimic AB

PRO · Nasdaq Stockholm · Healthcare

9.80SEK −3.0%last day

Price as of 2 October 2026

The price over the past year, with dividends: −41.0%

Performance

1 month

+23.3%

1 year

−41.0%

3 years, per year

−27.7%

5 years, per year

–

Largest fall, 3 years

−80.9%

Below the peak now

−75.8%

Volatility, 1 year

99.6%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

3.3

Dividend yield

0.0%

Return on equity

−14.1%

Net margin

−17.1%

Market value

18 m USD

Quality, value and trend

Where Promimic stands against every Nordic stock today. 100 is best.

Quality78

Profitability and a sound balance sheet over time. Better than 78% of Nordic stocks.

Value17

The price measured against earnings, assets and cash flow. Better than 17% of Nordic stocks.

Trend17

The price development over the past year. Better than 17% of Nordic stocks.

Combined24

Quality, value and trend together. Better than 24% of Nordic stocks.

About Promimic

Promimic AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 17 employees.

Promimic AB (publ) engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden. It offers HAnano surface which combines several properties that are known to improve osseointegration into one unique surface modification; and nano-sized crystalline powder or suspension hydroxyapatite can be used in r and d, as an ingredient in bone substitutes or as a chromatography material. The company was incorporated in 2004 and is headquartered in Mölndal, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis